WOODCLIFF LAKE, N.J. Eisai has announced its new hires, Kimberly Ray and Barbara Lewis.
Ray will become senior manager of the pharmacoepidemiology and risk management in medical services. She previously worked at Bristol-Myers Squibb as the associate manager, global pharmacovigilance, which is the pharmacological science relating to the detection, assessment, understanding and prevention of adverse effects, particularly long term and short term side effects of medicines, and epidemiology.
Lewis will be the director of global health economics and outcomes research. Prior to joining Eisai, she worked for AstraZeneca Pharmaceuticals as a field-based health economics and outcomes research director, where she worked with managed care organizations and large medical groups in the Northeast.